Information to Patients
European citizens are increasingly attentive towards new developments in public health which can positively affect their well-being. What is more, information can be easily collected by people, through different channels, such as newspapers, the mass media and the internet. As people play a leading role in the decisions about their own treatment, the dissemination of appropriate high-quality information has became of primary importance.
To ensure adequate information to patients on diseases and treatment options, the European Commission has been looking at different ways of improving the quality and accessibility of information within the High Level Pharmaceutical Forum and with the adoption of legal proposals on information to patients.